LONDON BRIEFING: GSK in USD12 billion drug portfolio deal with Hengrui
(Alliance News) - GSK announced a partnership with China's Hengrui, Cranswick said it expects results in line with market expectations, while STV warned of an annual outcome below consensus. Read More